BioLineRx Ltd. (TLV:BLRX)
1.200
0.00 (0.00%)
Apr 28, 2026, 5:28 PM IDT
BioLineRx Employees
As of December 31, 2025, BioLineRx had 24 total employees, including 20 full-time and 4 part-time employees. The number of employees decreased by 4 or -14.29% compared to the previous year.
Employees
24
Change (1Y)
-4
Growth (1Y)
-14.29%
Revenue / Employee
170.99K ILS
Profits / Employee
-170.27K ILS
Market Cap
31.33M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| BioLight Life Sciences | 4 |
| Can-Fite BioPharma | 5 |
| XTL Biopharmaceuticals | 10 |
| Purple Biotech | 10 |
| Matricelf | 15 |
| Geffen Residence & Renewal | 6 |
| Bonus BioGroup | 37 |
BioLineRx News
- 19 hours ago - BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) - PRNewsWire
- 20 days ago - BioLineRx (BLRX) Partners in Groundbreaking Glioblastoma Trial - GuruFocus
- 20 days ago - Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma - Business Wire
- 4 weeks ago - BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) - PRNewsWire
- 5 weeks ago - BioLineRx Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Earnings Scheduled For March 23, 2026 - Benzinga
- 5 weeks ago - BioLineRx Reports 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 5 weeks ago - BioLineRx (BLRX) and Others Set to Announce Earnings - GuruFocus